Evidence map›Paper›PMID 18215521›Full record

ReviewTrends in cell biology2008

AsSIRTing the DNA damage response.

Myriam Gorospe, Rafael de Cabo

Abstract readReview
In one paragraph

Review in Trends in cell biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. SIRT1 in Neurodegenerative Diseases: Molecular Mechanisms, Disease Relevance, and Therapeutic Potential.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Targeting Nuclear NADCancers · 2020
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. HDACs and HDAC Inhibitors in Cancer Development and Therapy.Cold Spring Harbor perspectives in medicine · 2016
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Myriam GorospeLaboratory of Cellular and Molecular Biology, National Institute on Aging - Intramural Research Program, National Institutes of Health, Baltimore, MD 21224, USA. myriam-gorospe@nih.gov
Rafael de Cabo

Funding

Aging Intervention ProgramZIAAG000363 · NIA · NATIONAL INSTITUTE ON AGING · PI DE CABO, RAFAEL · 2009 to 2025
$9.0M
Aging Intervention ProgramZ01AG000363 · NIA · NATIONAL INSTITUTE ON AGING · PI DE CABO, RAFAEL · 2008 to 2008
$628k
Influence of mRNA Turnover on the Biology of Cellular Senescence and AgingZ01AG000393 · NIA · NATIONAL INSTITUTE ON AGING · PI GOROSPE, MYRIAM NONE · 2008 to 2008
$265k
Intramural NIH HHS Z01 AG000393
6 · The paper itself

Abstract

In mammalian cells, changes in signaling networks and expressed proteins ensure the adequate detection and management of damaged macromolecules. Here, we review an emergent pathway of maintenance of homeostasis following genotoxic stress. The RNA-binding protein HuR associates with sirtuin (SIRT)1 mRNA and maintains constitutively elevated levels of SIRT1 protein, a deacetylase that elicits a prosurvival function. SIRT1 was recently shown to deacetylate the Nijmegen breakage syndrome (NBS1) protein, thereby rendering it phosphorylatable by ataxia telangiectasia mutated protein (ATM). A component of the MRN (MRE11-RAD50-NBS1) nuclease complex, NBS1 is crucial for sensing DNA damage and mounting a genotoxic response. This article covers the regulatory pathway of HuR-->SIRT1-->NBS1, through which post-transcriptional and post-translational effectors contribute to the maintenance of genomic integrity.

Indexed as

DNA DamageRNA, MessengerSirtuinsAnimalsAntigens, SurfaceCell Cycle ProteinsCell SurvivalDNA-Binding ProteinsELAV-Like Protein 1ELAV ProteinsGene Expression RegulationHumansNuclear ProteinsRNA-Binding ProteinsSignal TransductionSirtuin 1Antigens, SurfaceCell Cycle ProteinsDNA-Binding ProteinsELAVL1 protein, humanELAV-Like Protein 1ELAV ProteinsNijmegen breakage syndrome 1 protein, mouseNuclear ProteinsRNA-Binding ProteinsRNA, MessengerSirt1 protein, mouseSirtuin 1Sirtuins

Identifiers

PMID18215521
PMCPMC8483772

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.